Intellia Therapeutics (NTLA) Financials

$12.33

$-0.36 (-2.84%)

As on 23-Sep-2026 16:16EDT

Market cap

$1,701 Mln

Revenue (TTM)

$60 Mln

P/E Ratio

--

P/B Ratio

2.4

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Operating Revenue	59.51	67.67	57.88	36.28	52.12	33.05
Cost of Revenue	87.17	15.92	10.29	8.98	7.57	6.89
Gross Profit	-27.66	51.75	47.59	27.30	44.55	33.05
Operating Expenses	395.82	492.74	581.86	542.59	502.71	300.90
Operating Profit (EBIT)	-423.48	-440.99	-534.26	-515.29	-458.16	-267.85
Other Income	--	--	--	--	-17.66	0.04
Profit before Tax	-399.98	-412.69	-519.02	-481.19	-474.19	-267.89
Provision for Tax	--	--	--	-49.73	16.02	-8.17
Profit after Tax (Net Income)	-399.98	-412.69	-519.02	-481.19	-474.19	-259.72
Minority Interest	--	--	--	--	--	--
Consolidated Profit	--	--	--	--	-474.19	-267.89

Liabilities ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Shareholder's Funds	727.71	671.39	871.96	1,050.17	1,235.58	1,040.24
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	50.07	66.85	208.21	135.60	157.98	128.39
Current Liabilities	79.39	103.88	110.85	115.21	126.55	125.83
Total Liabilities	936.56	842.13	1,191.02	1,300.98	1,520.11	1,294.46

Assets ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Non-Current Assets	329.33	314.42	551.15	302.65	303.32	525.16
Current Assets	527.83	527.71	639.86	998.33	1,216.80	769.30
Total Assets	936.56	842.13	1,191.02	1,300.98	1,520.11	1,294.46
Total Debt*	73.41	93.33	210.20	115.35	130.70	74.02
Net Current Assets	448.44	423.83	529.01	883.12	1,090.24	643.47

Cashflow ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Cash From Operating Activities	--	-348.88	-348.88	-394.09	-333.29	-225.03
Cash Flow from Investing Activities	--	125.57	125.57	-31.35	160.31	-550.78
Cash from Financing Activities	--	185.75	185.75	130.32	582.96	736.69
Net Cash Inflow / Outflow	--	--	--	--	409.98	-39.12

Financials Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Adjusted EPS ($)	-3.41	-3.81	-5.10	-5.32	-5.84	-3.49
Cash EPS ($)	--	-3.66	-4.99	-5.22	-5.74	-3.40
Adjusted Book Value ($)	--	6.20	8.56	11.61	15.21	13.98
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	-3.22	-3.43	-4.36	-4.10	-3.02
Free Cash Flow per Share ($)	--	-3.27	-3.48	-4.51	-4.82	-3.19

Profitability Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
ROCE (%)	--	-44.69	-46.18	-38.01	-38.23	-30.91
ROE (%)	-57.18	-53.48	-54.00	-42.10	-41.67	-33.14
ROA (%)	-41.43	-40.60	-41.66	-34.11	-33.69	-26.36
EBIT Margin (%)	-672.16	-609.85	-896.77	-1,326.51	-909.78	-810.37
Net Margin (%)	-672.16	-609.85	-896.77	-1,326.51	-1,375.97	-784.77
Cash Profit Margin (%)	0.00	--	--	--	--	--

Growth Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Revenue Growth (%)	12.58	0.17	0.60	-0.30	0.58	-0.43
EBIT Growth (%)	16.71	20.49	-7.86	-1.48	-77.03	-96.11
Net Profit Growth (%)	16.71	20.49	-7.86	-1.48	-82.58	-106.83
EPS Growth (%)	27.20	0.25	0.04	0.09	-0.67	-0.70
Book Value Growth (%)	-20.93	--	--	--	--	--

Valuation Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Price / Earnings	--	-2.36	-2.29	-5.73	-5.98	-33.88
Price / Book Value	2.36	1.45	1.36	2.63	2.29	8.46
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	-5.51	-1.56	-1.57	-4.15	-3.80	-31.14
Close Price ($)	16.92	8.99	11.66	30.49	34.89	118.24
High Price ($)	28.24	28.24	34.87	47.48	126.95	202.73
Low Price ($)	7.95	5.90	11.34	22.67	32.72	43.86
Market Cap ($ Cr)	1,701.14	--	--	--	--	--

Solvency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debt to Equity	--	0.14	0.24	0.11	0.11	0.07
Short term debt to equity ratio	0.03	0.04	0.02	0.02	0.01	0.01
Current Ratio	6.65	5.08	5.77	8.67	9.61	6.11
Quick Ratio	6.65	--	--	--	10.16	8.79
Interest Coverage	--	--	--	--	-55.51	-38.87

Operating Efficiency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debtors to sales (%)	12.30	13.99	14.72	100.50	7.23	6.14
Asset Turnover	0.06	0.07	0.05	0.03	0.04	0.03
Receivable days	--	48.54	141.91	202.51	20.32	22.99
Inventory Days	--	--	--	-2,821.49	-9,808.95	-9,448.13
Payable days	--	399.60	391.37	256.48	357.12	533.03
Cash Conversion Cycle	--	--	--	-2,875.47	-10,145.76	-9,958.18

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.